Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cardio symbols : NVS save search
Global Nanomedicine Markets, 2015-2020, 2020-2025F, 2030F - Focus on Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics
Published: 2021-11-03 (Crawled : 23:00) - prnewswire.com
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
AMGN | News | $273.19 0.47% 360K
|
Health Technology
|
| O: 0.08%
H: 0.07%
C: -1.54%
disease infectious disease cardiology device cardio
Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events
Published: 2021-08-02 (Crawled : 17:00) - biospace.com/
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.33%
H: 0.15%
C: -0.16%
IONS | $42.23 2.82% 180K
|
Health Technology
|
| O: 0.24%
H: 2.2%
C: 1.07%
cardiovascular cardio trial enroll
Valuation in Geriatric Medicines Market to Reach US$ 1142.8 Bn by 2027, Use in Managing Cardiovascular Diseases Spurs Growth: TMR
Published: 2021-07-12 (Crawled : 15:00) - prnewswire.com
PFE | News A | $26.34 0.31% 7.7M
|
Health Technology
|
| O: 0.13%
H: 1.49%
C: 0.25%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.5%
H: 0.28%
C: -0.24%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: 0.22%
H: 0.94%
C: 0.3%
LLY | News | $742.04 1.46% 540K
|
Health Technology
|
| O: -0.98%
H: 1.2%
C: 0.36%
BMY | $49.35 0.43% 1.4M
|
Health Technology
|
| O: -0.15%
H: 1.19%
C: 0.66%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 1.84%
H: 0.27%
C: -0.38%
disease cardiovascular growth cardio
Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
Published: 2021-06-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.13%
QURE | $4.83 0.21% 140K
|
Health Technology
|
| O: 0.73%
H: 2.08%
C: 2.01%
SRPT | $119.28 1.98% 88K
|
Health Technology
|
| O: 0.15%
H: 1.37%
C: 0.75%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
CLLS | News | $2.64 19K
|
Health Technology
|
| O: -0.45%
H: 1.88%
C: 1.3%
BLUE | $1.025 7.49% 1.4M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.89%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.97%
H: 0.24%
C: -2.72%
disease neurological cardiovascular infectious disease gene therapy therapy cardio gene therapies rare
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.